SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

Clinical trial NCT02283775 · COMPLETED

Trial details

NCT number: NCT02283775
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2015-05-15
Primary completion: 2021-05-26
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.